- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03630016
SpO2 Accuracy Comparison of Smart Sock V. 2 SpO2 to Arterial Blood CO-Oximetry
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pulse oximetry monitoring is considered a standard physiological measurement and is used by clinicians in everyday situations to estimate arterial oxygen saturation. A pulse oximeter is a device that measures the oxygen saturation of arterial blood non-invasively.
The purpose of this study was to evaluate the SpO2 accuracy performance of the Owlet BabySat v1.0 and Smart SockTM 2 pulse oximetry OSS v1.1 sensors during non-motion conditions over the range of 70-100% SaO2 to arterial blood samples assessed by CO-Oximetry for a SpO2 validation.
The goal, in its entirety, was to show the SpO2 accuracy performance for the investigational device Owlet Baby Care, Inc. Smart SockTM V. 2.
It was expected that the Accuracy Root Mean Square (ARMS) performance would meet the required specification of ARMS 3% or lower in non-motion conditions for the range of 70 - 100% SaO2 thereby demonstrating an acceptable SpO2 accuracy performance specification.
No risks or adverse device effects were expected. There were no contraindications for use in the proposed study population.
The study was conducted in accordance to the code of federal regulations for non-significant risk medical device studies and applicable ISO 14155 (2nd edition 2011-02-01), applicable sections of ISO80601-2-61 (1st edition 2011-04- 01), and Pulse Oximeters - Premarket Notifications Submissions [510(k)s] Guidance For Industry and Food and Drug Administration Staff (issued: March 4, 2013)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Utah
-
Lehi, Utah, United States, 84043
- Owlet Baby Care, Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 10-15 Adults with a minimum of 3 males and a minimum of 3 females, with the balance, made up of either.
- Subject must have the ability to understand and provide written informed consent
- Subject is 18 to 50 years of age
- At least 2 darkly pigmented subjects or 15% of the subject pool, whichever is larger
- Subject must be willing and able to comply with study procedures and duration
- Subject is a non-smoker or who have not smoked within 2 days prior to the study.
Exclusion Criteria:
- Subject is considered as being morbidly obese (defined as BMI >39.5)
- Compromised circulation, injury, or physical malformation of fingers, toes, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study
- Females who are pregnant, who are trying to get pregnant
- Smoker Subjects who have refrained will be screened for COHb levels
- Subjects with known heart or cardiovascular conditions
- Subjects with known clotting disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Reference CO-Oximetry
Reference Co-Oximetry
|
A comparative, single-center, non-randomized study to evaluate the SpO2 accuracy guidelines for pulse oximetry over the range of 70-100% SaO2 under non-motion conditions.
Arterial blood sampling measured by functional SaO2 CO-Oximetry, was used as the basis for comparison with Owlet BabySat v1.0 and Owlet Smart Sock 2 sensors
|
Experimental: Owlet BabySat v1.0
|
A comparative, single-center, non-randomized study to evaluate the SpO2 accuracy guidelines for pulse oximetry over the range of 70-100% SaO2 under non-motion conditions.
Arterial blood sampling measured by functional SaO2 CO-Oximetry, was used as the basis for comparison with Owlet BabySat v1.0 and Owlet Smart Sock 2 sensors
|
Experimental: Owlet Smart Sock V2 v1.1
Owlet Smart SockTM 2 , OSS v1.1 Sensor and Custom Adult Thumb Sock
|
A comparative, single-center, non-randomized study to evaluate the SpO2 accuracy guidelines for pulse oximetry over the range of 70-100% SaO2 under non-motion conditions.
Arterial blood sampling measured by functional SaO2 CO-Oximetry, was used as the basis for comparison with Owlet BabySat v1.0 and Owlet Smart Sock 2 sensors
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
It Was Expected That the Accuracy Root Mean Square (ARMS) Between Measured SpO2 of Owlet Smart Sock V2 v1.1 and Reference SpO2 Would Meet the Required Specification of ARMS 3% or Lower in Non-motion Conditions for the Range of 70 - 100%
Time Frame: Acute immediate assessment of the sensor accuracy compared to CO-oximetry
|
The purpose of the study was to evaluate the accuracy of the blood oxygen saturation (SpO2) at rest over the range of 70-100% compared to arterial blood samples assessed by standard methods [Co-Oximetry].
A standard pulse oximeter accuracy is evaluated by the Accuracy Root Mean Square (ARMS).
The results of accurate performance of the oximetry system require ARMS of 3% or less in non-motion conditions for the range of 70-100% SpO2 per standard.
|
Acute immediate assessment of the sensor accuracy compared to CO-oximetry
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Milena Adamian, MD, Owlet Baby Care, Inc.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PR2017-263
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoxia
-
Western University, CanadaUnknownBrain Hypoxia IschemiaCanada
-
Yale UniversityTianjin Chest HospitalCompletedBrain Ischemia Hypoxia | Muscle; Ischemic | Muscle HypoxiaChina
-
Fliegerärztliches InstitutCompleted
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States
-
Owlet Baby Care, Inc.Completed
-
Robert L. OwensCompletedIntermittent HypoxiaUnited States
-
Montreal Heart InstituteUniversité de MontréalCompleted
-
United States Army Research Institute of Environmental...University of Puget SoundRecruiting
-
The University of Hong Kong-Shenzhen HospitalRecruiting
-
Sherief Abd-ElsalamRecruiting
Clinical Trials on Pulse oximetry with Owlet BabySat v1.0 sensor
-
Medline IndustriesClinimark, LLCTerminated
-
VA Pittsburgh Healthcare SystemMedline IndustriesCompletedHealthy | Peripheral Vascular Disease | VasoconstrictionUnited States
-
University of FloridaCompletedCongenital Cardiovascular MalformationUnited States
-
Masimo CorporationRecruiting
-
Ethicon Endo-SurgeryCompletedSedation for Non-Emergent Upper and/or Lower EndoscopyUnited States
-
Masimo CorporationCompleted
-
Cadwell Industries, Inc.Clinimark, LLCCompleted
-
Brno University HospitalMasaryk UniversityNot yet recruitingOxygen Saturation MeasurementCzechia